I 
118TH CONGRESS 
2D SESSION 
H. R. 8223 
To improve menopause care and mid-life women’s health, and for other 
purposes. 
IN THE HOUSE OF REPRESENTATIVES 
MAY 2, 2024 
Ms. BLUNT ROCHESTER (for herself and Ms. CLARKE of New York) intro-
duced the following bill; which was referred to the Committee on Energy 
and Commerce 
A BILL 
To improve menopause care and mid-life women’s health, 
and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE; TABLE OF CONTENTS. 
(a) SHORT TITLE.—This Act may be cited as the 
‘‘Advancing Menopause Care and Mid-Life Women’s 
Health Act’’. 
(b) TABLE OF CONTENTS.—The table of contents for 
this Act is as follows: 
Sec. 1. Short title; table of contents. 
Sec. 2. Research with respect to menopause and mid-life women’s health. 
Sec. 3. Public health promotion and prevention. 
VerDate Sep 11 2014 
04:19 May 30, 2024
Jkt 049200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6211
E:\BILLS\H8223.IH
H8223
kjohnson on DSK7ZCZBW3PROD with $$_JOB
Sec. 4. Public health awareness, education, and outreach program on meno-
pause and mid-life women’s health. 
Sec. 5. Training programs to improve care and treatment of menopausal symp-
toms. 
Sec. 6. Centers of excellence in menopause cause and mid-life women’s health. 
Sec. 7. Reporting requirement. 
Sec. 8. Coordination. 
SEC. 2. RESEARCH WITH RESPECT TO MENOPAUSE AND 
MID-LIFE WOMEN’S HEALTH. 
(a) NIH RESEARCH.—Part A of title IV of the Public 
Health Service Act (42 U.S.C. 281 et seq.) is amended 
by adding at the end the following: 
‘‘SEC. 404P. RESEARCH WITH RESPECT TO MENOPAUSE 
AND MID-LIFE WOMEN’S HEALTH. 
‘‘(a) RESEARCH AND INNOVATION.— 
‘‘(1) IN GENERAL.—The Director of NIH, act-
ing through the Director of the Office of Research 
on Women’s Health, shall coordinate and expand re-
search activities conducted by all institutes, centers, 
and offices of the National Institutes of Health to 
develop and implement Federal research programs 
with respect to— 
‘‘(A) the impact of the symptoms and tra-
jectories of changes across the menopausal 
transition and the postmenopausal period on 
women’s physical, mental, behavioral, and cog-
nitive health; and 
‘‘(B) the prevention of related adverse 
health outcomes among women during the men-
VerDate Sep 11 2014 
04:19 May 30, 2024
Jkt 049200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H8223.IH
H8223
kjohnson on DSK7ZCZBW3PROD with $$_JOB
opausal transition and the postmenopausal pe-
riod. 
‘‘(2) GRANTS.—In carrying out paragraph (1), 
the Director of NIH shall award grants to eligible 
entities to support— 
‘‘(A) biomedical and public health research 
and innovation in the development of new treat-
ments and diagnostic testing services for 
perimenopause and acute and chronic meno-
pausal symptoms; and 
‘‘(B) researchers and clinicians engaged in 
clinical and translational research on meno-
pause and mid-life women’s health. 
‘‘(3) ELIGIBLE ENTITIES.—To be eligible to re-
ceive a grant under subsection (b), an entity shall 
meet such criteria as the Director of NIH may es-
tablish, and shall be— 
‘‘(A) an accredited entity that offers edu-
cation to students in various health professions, 
such as— 
‘‘(i) a teaching hospital; 
‘‘(ii) an accredited school of medicine, 
osteopathic medicine, nursing, or phar-
macy, or a physician assistant training 
program, including a historically Black col-
VerDate Sep 11 2014 
04:19 May 30, 2024
Jkt 049200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H8223.IH
H8223
kjohnson on DSK7ZCZBW3PROD with $$_JOB
lege or university (as defined by the term 
‘part B institution’ in section 322 of the 
Higher Education Act of 1965 or described 
in section 326(e)(1) of the Higher Edu-
cation Act of 1965) or other minority-serv-
ing institutions (as described in section 
371(a) of the Higher Education Act of 
1965)); 
‘‘(iii) a certified behavioral health clin-
ic with an accredited medical or nursing 
residency program; 
‘‘(iv) an accredited public or nonprofit 
private hospital with an accredited medical 
or nursing residency program; 
‘‘(v) an accredited nurse practitioner 
residency program that includes and ac-
credited nursing residency program; or 
‘‘(vi) a related accredited program en-
gaged in the care, treatment, or manage-
ment of menopausal symptoms; 
‘‘(B) an academic research institution or 
other nonprofit research institution; 
‘‘(C) a small business; or 
‘‘(D) such other entity as the Director of 
NIH may determine appropriate. 
VerDate Sep 11 2014 
04:19 May 30, 2024
Jkt 049200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H8223.IH
H8223
kjohnson on DSK7ZCZBW3PROD with $$_JOB
‘‘(b) RESEARCH, CONDITION, AND DISEASE CAT-
EGORIZATION.—The Director of NIH shall designate, in 
the Research, Condition, and Disease Categorization, new 
categories for chronic or debilitating conditions among 
women, to analyze and coordinate current and future re-
search on menopause, menopausal symptoms, and short- 
term and long-term effects of such symptoms on mid-life 
women’s health. 
‘‘(c) COORDINATION.—The Director of the NIH shall 
coordinate and expand Federal research programs and ac-
tivities to study acute and chronic menopausal symptoms, 
including— 
‘‘(1) vasomotor symptoms; 
‘‘(2) osteoporosis; 
‘‘(3) sarcopenia; 
‘‘(4) temporomandibular disorders; 
‘‘(5) joint and nerve pain; 
‘‘(6) trauma, anxiety, depression, mood dis-
orders, and related mental and behavioral health 
conditions; 
‘‘(7) short-term memory loss; 
‘‘(8) genitourinary conditions; 
‘‘(9) alopecia; 
‘‘(10) vision or hearing impairments; 
‘‘(11) digestive and metabolic disorders; 
VerDate Sep 11 2014 
04:19 May 30, 2024
Jkt 049200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H8223.IH
H8223
kjohnson on DSK7ZCZBW3PROD with $$_JOB
‘‘(12) chronic sleep deficiency, insomnia, and 
related sleep disorders; and 
‘‘(13) other menopausal symptoms and related 
conditions, as the Director of NIH determines ap-
propriate. 
‘‘(d) TRANSLATIONAL RESEARCH.—The Secretary 
shall expand translational research activities to accelerate 
translation of Federal research on perimenopause and 
menopausal symptoms and facilitate equitable delivery of 
perimenopause and menopause care and related mid-life 
women’s health services. 
‘‘(e) OUTREACH AND ENGAGEMENT.—The Secretary 
shall expand outreach and engagement activities with ac-
credited schools of medicine, institutions of higher edu-
cation, and research institutions to support Federal re-
search activities with respect to menopausal symptoms.’’. 
(b) PUBLIC HEALTH RESEARCH AND DATA REPORT-
ING ACTIVITIES.—Part A of title III of the Public Health 
Service Act (42 U.S.C. 241 et seq.) is amended by adding 
at the end the following: 
‘‘SEC. 310C. RESEARCH RELATING TO MID-LIFE WOMEN’S 
HEALTH. 
‘‘(a) PUBLIC HEALTH RESEARCH.—The Secretary 
shall expand research activities with respect to the severity 
and duration of menopausal symptoms and related chronic 
VerDate Sep 11 2014 
04:19 May 30, 2024
Jkt 049200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H8223.IH
H8223
kjohnson on DSK7ZCZBW3PROD with $$_JOB
conditions affecting mid-life health outcomes among 
women, including mental and behavioral health outcomes. 
In carrying out activities under this section, the Secretary 
shall coordinate with existing programs and activities of 
the Department of Health and Human Services. 
‘‘(b) HEALTH CARE QUALITY RESEARCH.—The Sec-
retary shall expand research, program evaluation, and 
quality improvement activities to improve health care de-
livery for the care, treatment, or management of 
perimenopause and menopausal symptoms and related 
chronic conditions, including data collection with respect 
to preventive services that support mid-life health out-
comes among women and barriers to care. 
‘‘(c) DASHBOARD.—The Secretary shall establish and 
maintain a dashboard for the reporting of data on meno-
pausal symptoms and mid-life health outcomes among 
women gathered through public health surveillance activi-
ties with respect to screening, testing, treatment, and pre-
vention services, and the impact of this section and section 
404P on such efforts. 
‘‘(d) OCCUPATIONAL HEALTH RESEARCH.—The Sec-
retary shall conduct research activities and expand data 
collection with respect to workplace stressors related to se-
vere acute or chronic menopausal symptoms, physical in-
jury, or other adverse health outcomes among women, in-
VerDate Sep 11 2014 
04:19 May 30, 2024
Jkt 049200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H8223.IH
H8223
kjohnson on DSK7ZCZBW3PROD with $$_JOB
cluding traumatic stress, anxiety, depression, and related 
mental and behavioral health conditions. The Secretary 
shall review existing evidence, identify gaps in services, 
and develop evidence-informed recommendations for re-
lated public health interventions and support services. 
‘‘(e) INTERAGENCY COORDINATION.—The Secretary 
shall develop and implement new interagency research ini-
tiatives or programs to address menopausal symptoms.’’. 
(c) AUTHORIZATION OF APPROPRIATIONS.—For the 
purpose of carrying out sections 404P and 310C of the 
Public Health Service Act, as added by subsections (a) 
and (b), respectively, there are authorized to be appro-
priated $25,000,000 for each of fiscal years 2025 through 
2029. 
SEC. 3. PUBLIC HEALTH PROMOTION AND PREVENTION. 
Title III of the Public Health Service Act (42 U.S.C. 
241 et seq.) is amended by adding at the end the fol-
lowing: 
‘‘PART W—ACTIVITIES TO PROMOTE MID-LIFE 
WOMEN’S HEALTH 
‘‘SEC. 399OO. PUBLIC HEALTH PROMOTION ACTIVITIES. 
‘‘(a) CHRONIC CONDITIONS AND PUBLIC HEALTH 
PROMOTION.—The Secretary shall expand public health 
promotion and prevention activities with respect to mid- 
life women’s health and chronic conditions, including dia-
VerDate Sep 11 2014 
04:19 May 30, 2024
Jkt 049200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6201
E:\BILLS\H8223.IH
H8223
kjohnson on DSK7ZCZBW3PROD with $$_JOB
betes, hypertension, heart disease, iron-deficiency anemia, 
inflammation, fibroids, endometriosis, and other related 
conditions and adverse health outcomes, at the discretion 
of the Secretary. 
‘‘(b) EARLY DETECTION, DIAGNOSIS, AND TREAT-
MENT.— 
‘‘(1) IN GENERAL.—The Secretary shall award 
grants to eligible entities to improve the early detec-
tion, diagnosis, and treatment of perimenopause and 
menopausal symptoms and support public health ac-
tivities to expand access to quality care services and 
improve mid-life health outcomes among women. 
‘‘(2) ELIGIBLE ENTITIES.—To be eligible to re-
ceive a grant under paragraph (1), an entity shall— 
‘‘(A) be— 
‘‘(i) a State, local, Tribal, or terri-
torial public health department; 
‘‘(ii) an accredited entity that offers 
education to students in various health 
professions; or 
‘‘(iii) such other type of entity, as the 
Secretary determines appropriate; and 
‘‘(B) submit an application to the Sec-
retary at such time, in such manner, and con-
VerDate Sep 11 2014 
04:19 May 30, 2024
Jkt 049200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6201
E:\BILLS\H8223.IH
H8223
kjohnson on DSK7ZCZBW3PROD with $$_JOB